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Available online 26 January 2017The relationships of physical activity and sedentary time with all-cause mortality in those at high risk of type 2
diabetesmellitus (T2DM) are unexplored. To address this gap in knowledge, we examined the associations of ob-
jectively measured moderate-to-vigorous-intensity physical activity (MVPA) and sedentary time with all-cause
mortality in a population of adults at high risk of T2DM. In 2010–2011, 712 adults (Leicestershire, U.K.), identified
as being at high risk of T2DM, consented to be followedup formortality.MVPA and sedentary timewere assessed
by accelerometer; those with valid data (≥10 hours of wear-time/day with ≥4 days of data) were included. Cox
proportional hazards regression models, adjusted for potential confounders, were used to investigate the inde-
pendent associations of MVPA and sedentary time with all-cause mortality. 683 participants (250 females
(36.6%)) were included and during a mean follow-up period of 5.7 years, 26 deaths were registered. Every 10%
increase in MVPA time/day was associated with a 5% lower risk of all-cause mortality [Hazard Ratio (HR): 0.95
(95% Confidence Interval (95% CI): 0.91, 0.98); p= 0.004]; indicating that for the average adult in this cohort un-
dertaking approximately 27.5 minutes of MVPA/day, this benefit would be associated with only 2.75 additional
minutes of MVPA/day. Conversely, sedentary time showed no association with all-cause mortality [HR (every
10-minute increase in sedentary time/day): 0.99 (95% CI: 0.95, 1.03); p= 0.589]. These data support the impor-
tance of MVPA in adults at high risk of T2DM. The association between sedentary time andmortality in this pop-
ulation needs further investigation.
© 2017 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Mortality
Physical activity
Moderate-to-vigorous-intensity physical activity
Sedentary
Type 2 diabetes mellitus
Cox proportional hazards regression1. Introduction
Diabetes is a leading health care burden nationally and internation-
ally (NCD Risk Factor Collaboration, 2016). Therefore, the prevention of
diabetes, particularly type 2 diabetes mellitus (T2DM), is an identifiedniversity of Leicester, Leicester
re, LE5 4PW, United Kingdom.
le.ac.uk (C.L. Edwardson),
amer@lboro.ac.uk (M. Hamer),
(T. Yates).
en access article under the CC BY-NChealth care priority. Diabetes prevention has focused on the promotion
of established health behaviours, including physical activity,with strong
evidence of efficacy (Gillies et al., 2007). However, whilst the effects of
promoting physical activity and other lifestyle factors on reducing the
risk of T2DM are well-known in those at high risk of T2DM (defined
as non-diabetic hyperglycaemia), the strength of association with all-
causemortality is less clear. To our knowledge, only one studyhas quan-
tified the associations between objectively measured physical activity
and mortality/morbidity outcomes in those at high risk of T2DM
(Yates et al., 2014), whilst no studies have examined associations with
objectively measured sedentary time. The latter is important given the
mounting evidence that sedentary behaviour, defined as sitting or-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
286 K. Bakrania et al. / Preventive Medicine Reports 5 (2017) 285–288reclining with low energy expenditure, is associated with poor health
and has been advocated as an important behavioural target in the pre-
vention of diabetes (Henson et al., 2016).
This brief report quantifies the associations of objectively measured
moderate-to-vigorous-intensity physical activity (MVPA) and seden-
tary time with all-cause mortality in a population of adults at high risk
of T2DM recruited from primary care.
2. Methods
2.1. Design and population
Participants for this study were part of theWalking Away from Type
2 Diabetes trial (Yates et al., 2012). The trial consisted of adults at an in-
creased risk of T2DMwhowere recruited in 2010–2011 through 10 pri-
mary care practices in Leicestershire, United Kingdom. Individuals (n=
833)with an increased risk of non-diabetic hyperglycaemia (defined as:
impaired glucose tolerance (IGT) and/or impaired fasting glycaemia
(IFG)) or undiagnosed T2DM were identified for recruitment using the
Leicester Risk Score (Yates et al., 2012). At baseline, participants were
randomised to usual care or the three-hour Walking Away structured
education programme with ongoing annual support (Yates et al.,
2012). Participants were followed up at 12, 24 and 36 months. Over
the 36 months, no overall difference was observed in levels of physical
activity or sedentary behaviour between the two arms (Yates et al.,
2016). This brief report uses the baseline data and includes the 712
adults within the cohort who consented to have their records follow-
ed-up for health status. All participants provided written informed con-
sent and the study was approved by the Nottingham Research Ethics
Committee, United Kingdom.
2.2. Mortality data
Mortality data were obtained from the Office for National Statistics
(ONS) via an application to the Health and Social Care Information
Centre (HSCIC). All-cause mortality was defined as any death recorded
between baseline and end of data linkage on 6 April 2016. All-cause
mortality was coded as a binary variable representing censoring or
death. For censored data, survival time (in days) was defined as the dif-
ference between the follow-up date (6 April 2016) and the date of base-
line visit. For event data, survival time was defined as the difference
between the date of death and baseline visit.
2.3. Physical activity and sedentary time data
MVPA and sedentary timewere measured using an ActiGraph GT3X
accelerometer (ActiGraph Corporation, Pensacola, Florida, USA) which
was worn on the right hip for seven consecutive days during waking
hours. Accelerometer files were processed using KineSoft V3.3.76
(KineSoft, Loughborough,United Kingdom). TheActiGraphGT3Xdevice
was initialised to collect data using 15 seconds epochs, and files were
reintegrated into one minute epochs. Accelerometer counts derived
from the vertical axis were used to calculate the amount of time spent
in sedentary behaviour (b100 cpm) and in MVPA (≥1952 cpm)
(Freedson et al., 1998; Matthews et al., 2008). Non-wear time was
defined as any periods of continuous zero counts for ≥60 consecutive
minutes. Valid accelerometer data were defined as ≥10 hours of wear-
time/day with ≥4 days of data. Participants who provided valid acceler-
ometer datawere retained for analysis. The average number ofminutes/
valid day spent sedentary and in MVPA were calculated.
2.4. Anthropometric, demographic and lifestyle data
The following data were also utilised: age (years), body mass index
(BMI: kg/m2), ethnicity (white, non-white), sex (male, female), smoking
status (non-smoker, smoker), medical history of cardiovascular disease(myocardial infarction, heart failure, angina and/or stroke), blood pres-
sure and/or cholesterol medication (ACE-inhibitors, alpha-blockers, an-
giotensin-II receptor antagonists, beta-blockers, calcium channel
blockers, lipid lowering statins and/or lipid lowering fibrates), aspirin
medication, and accelerometer wear-time. Body weight (Tanita TBE
611; Tanita, West Drayton, United Kingdom) and height were measured
to the nearest 0.1 kg and 0.5 cm, respectively. BMI was calculated as the
weight (in kilograms) divided by the square of the height (in metres).
2.5. Statistical analysis
Statistical analyseswere conducted using Stata/MPV14.0 (Stata Cor-
poration, College Station, Texas, USA). Data were analysed in August
2016.
Participant characteristics, stratified by mortality status, were tabu-
lated. Categorical variableswere presented as numbers and proportions,
whereas continuous variables were summarised asmeans and standard
deviations. A series of Cox proportional hazards regression models
(with survival time in days) were used to investigate the independent
associations of MVPA and sedentary time with all-cause mortality
(Cox, 1972). MVPA time indicated a non-normal distribution; therefore,
it was log-transformed to reduce the influence of skewed data. To en-
sure that the hazard ratios represented a 10% increase in MVPA time/
day, a log base of 1.1 (i.e. log1.1 (MVPA time)) was used. Sedentary be-
haviour was presented as a 10-minute increase in sedentary time/day.
Model 1 adjusted for: age, sex and smoking status. Model 2 further ad-
justed for sedentary time (for MVPA time analysis) andMVPA time (for
sedentary time analysis). Model 3 further adjusted for BMI. Ethnicity,
accelerometer wear-time, medical history of cardiovascular disease,
blood pressure and/or cholesterol medication, and aspirin medication
were also individually considered as covariates in theminimally adjust-
ed model (i.e. Model 1). However, their inclusion did not affect the haz-
ard ratios, direction of association or interpretation (significance/non-
significance) of the models (see Supplementary Table S1). Therefore,
in order to maintain an adequate ratio between the number of events
and covariates in the model (Vittinghoff and McCulloch, 2007), the
more parsimonious model was used.
The proportional hazards assumption of each model was assessed
via: a) plotting the Schoenfeld residuals against time; and b) executing
a formal post-hoc proportional hazards global test (Stata command:
‘estat phtest’). All reported p-values were two-sided with p b 0.05 con-
sidered statistically significant.
2.6. Sensitivity analysis
Since smokers are generally more likely to be physically inactive in
comparison to non-smokers, they could potentially modify the associa-
tions with all-cause mortality. Therefore, in order to assess the robust-
ness and replicability of our findings, we repeated our main analysis
(Models 1, 2 and 3) in the sample of non-smokers.
3. Results
Of the 712 individuals who consented for data linkage, 683 partici-
pants [mean age (standard deviation (SD)) = 63.6 (7.8) years; mean
BMI (SD) = 32.0 (5.3) kg/m2; 250 females (36.6%)] provided valid ac-
celerometer data and were included for analysis. During a mean fol-
low-up period of 5.7 years, 26 deaths were registered. Table 1 displays
the characteristics of the included participants further stratified bymor-
tality status.
In the maximally adjusted model (Model 3), every 10% increase in
MVPA time/daywas associatedwith a 5% lower risk of all-causemortal-
ity [Hazard Ratio (HR): 0.95 (95% Confidence Interval (95% CI): 0.91,
0.98); p = 0.004]. Conversely, sedentary time showed no association
with all-cause mortality [HR (every 10-minute increase in sedentary
time/day): 0.99 (95% CI: 0.95, 1.03); p = 0.589]. The proportional
Table 1
Participant characteristics stratified by mortality status (Walking Away from Type 2 Dia-
betes trial, 2010–2011, Leicestershire, United Kingdom).
Characteristic Sample
(n = 683)
Censored
(n = 657)
Deaths
(n = 26)
Age (years)a 63.6 (7.8) 63.6 (7.8) 64.4
(8.0)
Body mass index (kg/m2)a 32.0 (5.3) 32.0 (5.3) 33.2
(6.8)
Ethnicityb
White 608 (89.0) 584 (88.9) 24 (92.3)
Non-white 75 (11.0) 73 (11.1) 2 (7.7)
Sexb
Male 433 (63.4) 412 (62.7) 21 (80.8)
Female 250 (36.6) 245 (37.3) 5 (19.2)
Smoking statusb
Non-smoker 630 (92.2) 609 (92.7) 21 (80.8)
Smoker 53 (7.8) 48 (7.3) 5 (19.2)
Medical history of cardiovascular diseaseb
No 609 (87.2) 589 (89.7) 20 (76.9)
Yes 74 (10.8) 68 (10.3) 6 (23.1)
Currently taking blood pressure and/or
cholesterol medicationb
No 295 (43.2) 285 (43.4) 10 (38.5)
Yes 388 (56.8) 372 (56.6) 16 (61.5)
Currently taking aspirin medicationb
No 577 (84.5) 559 (85.1) 18 (69.2)
Yes 106 (15.5) 98 (14.9) 8 (30.8)
Accelerometer wear-time (average number
of minutes per valid day)a
855.5
(79.2)
856.3
(79.0)
834.6
(81.7)
Moderate-to-vigorous-intensity physical
activity time (average number of minutes
per valid day)a
27.5
(24.4)
27.8
(24.5)
19.0
(19.5)
Sedentary time (average number of minutes
per valid day)a
538.0
(92.1)
537.5
(91.1)
551.5
(116.5)
Survival time (number of years)a 5.6 (0.5) 5.7 (0.2) 3.9 (1.4)
a Continuous variable: mean (standard deviation).
b Categorical variable: number (%).
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siduals showing no trend with time and all global tests reporting
p N 0.05. Table 2 displays the results from the Cox proportional hazards
regression analyses.
Supplementary Table S1 displays the findings of the minimally ad-
justed model (Model 1) that individually considered all other
confounders.
Supplementary Table S2 displays the findings of the sensitivity anal-
ysis where the main analysis (Models 1, 2 and 3) was repeated in the
sample of non-smokers (n = 630; mean follow-up period of
5.6 years; 21 deaths). Our findings were robust and generalizable.
4. Discussion
Our findings demonstrate that the risk of death was reduced by 5%
for every 10% increase in MVPA time in adults at high risk of T2DM.
This indicates that for the average adult in this cohort undertakingTable 2
Cox proportional hazards regression models showing the associations of moderate-to-vigorous
Away from Type 2 Diabetes trial, 2010–2011, Leicestershire, United Kingdom).
Cox proportional hazards regression model log1.1 (MVPA time (minutes/
Hazard ratio (95% CI)a
Model 1 0.94 (0.91, 0.98)
Model 2 0.94 (0.91, 0.97)
Model 3 0.95 (0.91, 0.98)
Bold indicates statistical significance at p-value = 0.05.
Model 1 adjusted for: age, sex and smoking status.
Model 2 further adjusted for: sedentary time (for MVPA time analysis) and MVPA time (for se
Model 3 further adjusted for: body mass index.
a Hazard ratios represent the risk of all-cause mortality for every log1.1-unit increase in MVP
b Hazard ratios represent the risk of all-cause mortality for every 10-unit increase in sedentapproximately 27.5minutes of MVPA/day, this benefit would be associ-
atedwith only 2.75 additional minutes ofMVPA/day. In contrast, seden-
tary time was not associated with all-cause mortality.
Previous research has consistently shown that both MVPA and sed-
entary behaviour are associated with all-cause mortality (Biswas et al.,
2015; Nocon et al., 2008; Samitz et al., 2011;Wilmot et al., 2012). How-
ever, the majority of the studies in this research area have been limited
by self-reported measures, which rely on recall and suffer from re-
sponse bias; hence, they tend to have low validity and high levels of
measurement error. Few studies have examined the associations of
MVPA and sedentary time with mortality using objective measure-
ments. In a national sample of US adults with objectively measured
data, Schmid and colleagues observed that both low levels of MVPA
and high levels of sedentary behaviour were independently associated
with early all-cause mortality (Schmid et al., 2015). Other studies have
reported similar findings (Fishman et al., 2016; Loprinzi et al., 2016).
In contrast, a recent study in a subset of participants with diabetes
from this national survey showed no associations between sedentary
time and all-cause mortality after adjusting for total physical activity
(Loprinzi and Sng, 2016). However, all of these studies utilised the
same survey dataset; thus, the relationships need testing in other pop-
ulations including those at a high risk of T2DM.
Our results for MVPA are consistent with other studies that have
looked at the associations of pedometer assessed physical activity or
cardiorespiratory fitness with mortality in similar cohorts. An interna-
tional study reported that the risk of cardiovascular disease morbidity
and mortality was reduced by 8% for every 2000 steps/day increase in
walking activity (corresponds to approximately 20 minutes/day of
MVPA based on a cadence of 100 steps/minute) in those at high risk of
T2DM (Yates et al., 2014), with another study showing that the risk of
mortality was reduced with higher fitness in those with IGT or undiag-
nosed T2DM (Lyerly et al., 2009).
4.1. Strengths and limitations
This study has strengths and limitations. Strengths include the
utilisation of objectively measured MVPA and sedentary behaviour
data; a high risk sample; and a robust statistical analysis plan. The key
limitation was the low number of events. However, it has previously
been shown that Cox proportional hazards regression analysis can po-
tentially be considered as a robust estimation method even with a low
number of events. A ratio of the number of events to the number of pre-
dictor variables of approximately 5 or more has been shown to produce
accurate estimates in Cox proportional hazardsmodels (Vittinghoff and
McCulloch, 2007). In our study, the principles of parsimony were
followed and only a small number of key covariates were adjusted for;
this also prevented any overfitting of the models. However, although
our findings were unaffected after additionally adjusting for other po-
tential confounders (ethnicity, accelerometerwear-time,medical histo-
ry of cardiovascular disease, blood pressure and/or cholesterol
medication, and aspirin medication) it is possible that other factors-intensity physical activity (MVPA) and sedentary time with all-cause mortality (Walking
day)) Sedentary time (10 minutes/day)
p-Value Hazard ratio (95% CI)b p-Value
0.001 1.01 (0.97, 1.06) 0.538
0.001 0.99 (0.95, 1.03) 0.604
0.004 0.99 (0.95, 1.03) 0.589
dentary time analysis).
A time/day (i.e. for every 10% increase in MVPA time/day).
ary time/day (i.e. for every 10-minute increase in sedentary time/day).
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tributing to the observed association betweenMVPA and all-causemor-
tality. In addition to the ratio of events per predictor variable, large
regression coefficients and high correlations between predictor vari-
ables can cause issues in the approximation process (Courvoisier et al.,
2011). All of our model coefficients were small and there were low cor-
relations between the predictors in our models (data not shown). Nev-
ertheless, these results should be interpretedwith caution; in particular,
the non-significant association with sedentary time could be due to a
type II error arising from a lack of statistical power.
5. Conclusions
In conclusion, these data support the importance of MVPA in adults
at high risk of T2DM. However, more research is required to assess
whether objectively measured sedentary time is associated with health
outcomes in those at high risk of T2DM independently of MVPA.
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